Cytosorbents Past Earnings Performance
Past criteria checks 0/6
Cytosorbents's earnings have been declining at an average annual rate of -16.1%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 8.9% per year.
Key information
-16.1%
Earnings growth rate
-7.0%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 8.9% |
Return on equity | -122.5% |
Net Margin | -78.4% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?
Mar 16Take Care Before Jumping Onto Cytosorbents Corporation (NASDAQ:CTSO) Even Though It's 28% Cheaper
Jan 06Is Cytosorbents (NASDAQ:CTSO) Using Too Much Debt?
Nov 10Shareholders Should Be Pleased With Cytosorbents Corporation's (NASDAQ:CTSO) Price
Jul 13Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?
May 16We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate
Mar 08CytoSorbents secures $4.3M contract by U.S. Department of Defense
Oct 06CytoSorbents stock rises on US DoD contract to develop device for universal plasma
Sep 09We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate
Sep 02CytoSorbents gets reimbursement for CytoSorb in Turkey
Aug 23CytoSorbents stock rises 10% as Israel approves coverage for CytoSorb system
Aug 17Cytosorbents GAAP EPS of -$0.25 misses by $0.13, revenue of $8.5M misses by $1.06M
Aug 02We're Not Very Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate
Mar 03Revenue & Expenses BreakdownBeta
How Cytosorbents makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 36 | -29 | 37 | 16 |
30 Sep 23 | 37 | -23 | 36 | 15 |
30 Jun 23 | 36 | -26 | 36 | 15 |
31 Mar 23 | 35 | -31 | 36 | 15 |
31 Dec 22 | 35 | -33 | 37 | 15 |
30 Sep 22 | 36 | -41 | 39 | 18 |
30 Jun 22 | 38 | -36 | 38 | 19 |
31 Mar 22 | 41 | -29 | 40 | 18 |
31 Dec 21 | 43 | -25 | 38 | 16 |
30 Sep 21 | 44 | -16 | 37 | 13 |
30 Jun 21 | 45 | -10 | 36 | 10 |
31 Mar 21 | 43 | -9 | 33 | 9 |
31 Dec 20 | 41 | -8 | 32 | 9 |
30 Sep 20 | 36 | -11 | 29 | 10 |
30 Jun 20 | 32 | -17 | 28 | 11 |
31 Mar 20 | 28 | -18 | 26 | 12 |
31 Dec 19 | 25 | -19 | 24 | 12 |
30 Sep 19 | 24 | -21 | 24 | 11 |
30 Jun 19 | 23 | -17 | 22 | 10 |
31 Mar 19 | 23 | -19 | 23 | 8 |
31 Dec 18 | 23 | -17 | 23 | 8 |
30 Sep 18 | 21 | -15 | 21 | 7 |
30 Jun 18 | 19 | -14 | 21 | 6 |
31 Mar 18 | 17 | -10 | 18 | 4 |
31 Dec 17 | 15 | -9 | 16 | 3 |
30 Sep 17 | 14 | -11 | 15 | 3 |
30 Jun 17 | 12 | -10 | 14 | 4 |
31 Mar 17 | 11 | -11 | 13 | 4 |
31 Dec 16 | 10 | -12 | 13 | 4 |
30 Sep 16 | 8 | -9 | 10 | 4 |
30 Jun 16 | 7 | -10 | 10 | 4 |
31 Mar 16 | 6 | -5 | 9 | 4 |
31 Dec 15 | 5 | -9 | 8 | 4 |
30 Sep 15 | 4 | -17 | 8 | 4 |
30 Jun 15 | 4 | -17 | 7 | 4 |
31 Mar 15 | 4 | -21 | 7 | 3 |
31 Dec 14 | 4 | -19 | 6 | 2 |
30 Sep 14 | 4 | -9 | 5 | 1 |
30 Jun 14 | 4 | -8 | 5 | 1 |
31 Mar 14 | 3 | -7 | 4 | 1 |
31 Dec 13 | 2 | -7 | 3 | 2 |
30 Sep 13 | 2 | -7 | 3 | 2 |
30 Jun 13 | 2 | -7 | 3 | 3 |
Quality Earnings: CTSO is currently unprofitable.
Growing Profit Margin: CTSO is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CTSO is unprofitable, and losses have increased over the past 5 years at a rate of 16.1% per year.
Accelerating Growth: Unable to compare CTSO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CTSO is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: CTSO has a negative Return on Equity (-122.48%), as it is currently unprofitable.